The Oral Iron Chelator Deferasirox Induces Apoptosis in Myeloid Leukemia Cells by Targeting Caspase

Publisher： Karger

E-ISSN： 1421-9662|126|4|241-245

ISSN： 0001-5792

Source： Acta Haematologica, Vol.126, Iss.4, 2011-09, pp. : 241-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Deferasirox: a novel, once-daily oral iron chelator

By Cappellini Maria Domenica  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 453-460

Future Medicine

Access to resources Recommend Favorite

The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 2, 2015-07 ,pp. : 236-246

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral Iron Chelator Deferasirox in the Treatment of Secondary Hemochromatosis following Bone Marrow Transplantation in a Patient with Severe Aplastic Anemia

By  

Acta Haematologica, Vol. 125, Iss. 4, 2011-01 ,pp. : 219-221

Karger

Access to resources Recommend Favorite

ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 3, 2015-08 ,pp. : 698-709

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antifibrotic activity of deferasirox

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 638-645

John Wiley & Sons Inc

Access to resources Recommend Favorite